Archived explainer. For the current picture see today's COR page.
Why Is CENCORA INC Series A (COR) Stock Down Today?
By the Top Tier Newswire AI Desk · August 13, 2026 at 7:37 AM ET · reviewed against 9 wire stories
CENCORA INC Series A (COR) is down -5.90% in the latest session. Our newswire has captured 9 stories on COR across 7 sources in the last 36 hours, with AI sentiment reading mixed (avg 51/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Cencora Inc. stock fell 5.90% to $314.17 on Wednesday, driven primarily by the announcement that certain Walgreens business volume will shift away from the company starting July 1, 2026. The move comes despite Cencora reaffirming its 2026 adjusted diluted EPS guidance and maintaining its prime vendor agreement with Walgreens. The stock’s decline reflects investor concern over the loss of a portion of this business, which has historically contributed to the company’s revenue.
What Happened
Cencora disclosed in a recent SEC 8-K filing that beginning July 1, 2026, some Walgreens volume previously serviced by Cencora will be handled by external parties. This shift follows a broader restructuring of the partnership, though the prime vendor agreement remains unchanged. The company reiterated its full-year 2026 adjusted diluted EPS guidance range of $17.75 to $17.95. Despite this, the market reacted negatively, with the stock falling sharply in early trading. The news was highlighted in multiple reports, including from Seeking Alpha and Benzinga, which emphasized the operational impact of the shift. The stock’s underperformance was also noted in comparison to its peers, according to MarketWatch.
What The Data Shows
Cencora’s stock opened at $315.44 and traded within a narrow range throughout the session, reaching a high of $315.50 and a low of $315.44. Volume remained flat at 0.0M shares, matching the 3-month average. The stock is currently trading within its 52-week range of $244.82 to $377.54. Fundamentals show a market cap of $62.0B, a P/E ratio of 24.7, and a net margin of 0.8%. Recent insider transactions include three buys totaling $2.3M, with no sales reported in the last 90 days. Congressional trades show two buys and six sells in the same period.
What To Watch
Cencora’s Q3 2026 earnings call is scheduled for later in the year, where the company will provide further details on its performance amid the Walgreens transition. Investors should also monitor coverage breadth, as nine stories have emerged in the last 36 hours across seven sources, indicating growing attention to the company’s strategic developments.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
COR · today's session (5-min) · -1.32% vs prior close · updated 4:09 PM ETAI sentiment, last 36h · averaged over 9 stories · 51/100 neutral
The headlines behind the move
Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
1d agoMarketWatchBEARISH 42General
Cencora Inc. stock underperforms Wednesday when compared to competitors
1d agoInvesting.com MarketsBEARISH 42General
Why is Cencora stock sliding today?
Why is Cencora stock sliding today?
1d agoSeeking AlphaBEARISH 38General
Cencora dips on loss of some Walgreens business
Cencora (COR) stock dips as Walgreens-related operations move to external parties in July; prime vendor deal stays. Read more here.
1d agoTipRanksBULLISH 56General
Cencora Reaffirms 2026 EPS Outlook Amid Walgreens Shift
Cencora ( ($COR) ) just unveiled an announcement. Beginning July 1, 2026, certain Walgreens volume that had been serviced by Cencora outside its prime vendor agreem...
Revenue hit $84.8 billion as GLP-1 sales surged 25% despite manufacturer price headwinds.
1d agoBarchartBULLISH 63Analyst
Is Wall Street Bullish or Bearish on Cencora Stock?
Cencora has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →